Accessibility Menu
Sensus Healthcare Stock Quote

Sensus Healthcare (NASDAQ: SRTS)

$3.27
(-2.1%)
-0.07
Price as of October 27, 2025, 3:55 p.m. ET

KEY DATA POINTS

Current Price
$3.26
Daily Change
(-2.1%) $0.07
Day's Range
$3.25 - $3.42
Previous Close
$3.26
Open
$3.38
Beta
0.91
Volume
55,047
Average Volume
126,960
Market Cap
54.9M
Market Cap / Employee
$3.34M
52wk Range
$3.03 - $9.33
Revenue
-
Gross Margin
0.52%
Dividend Yield
N/A
EPS
-$0.05
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Sensus Healthcare Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SRTS-48.82%+28.09%+5.08%-43%
S&P+18.37%+110.18%+16.02%+217%

Sensus Healthcare Company Info

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$7.32M-20.8%
Gross Profit$2.90M-46.5%
Gross Margin39.69%-19.0%
Market Cap$77.95M-10.8%
Market Cap / Employee$1.44M0.0%
Employees5454.3%
Net Income-$1.04M-164.3%
EBITDA-$1.79M-186.6%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$22.16M16.8%
Accounts Receivable$12.62M-31.0%
Inventory15.1-6.3%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.34M-31.8%
Short Term Debt$0.25M29.2%

Ratios

Q2 2025YOY Change
Return On Assets-1.45%-13.5%
Return On Invested Capital9.59%3.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$3.09M-26.9%
Operating Free Cash Flow$3.12M-26.3%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q1 2025YoY Change
Price to Earnings13.0710.1517.0243.04223.36%
Price to Book1.802.101.401.47-13.86%
Price to Sales2.302.721.962.06-13.98%
Price to Tangible Book Value1.802.101.401.47-13.86%
Price to Free Cash Flow TTM45.3416.7022.15-
Enterprise Value to EBITDA45.6549.63-23.54-31.25-193.65%
Free Cash Flow Yield2.2%6.0%4.5%-
Return on Equity18.9%12.7%3.5%-1.6%-112.03%
Total Debt$0.65M$0.60M$0.65M$0.60M-14.76%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.